Aristippos Gennadios's most recent trade in Catalent Inc. was a trade of 1,169 Common Stock done at an average price of $59.6 . Disclosure was reported to the exchange on Aug. 2, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Catalent Inc. | Aristippos Gennadios | Group Pres. Pharma & Consumer | Sale of securities on an exchange or to another person at price $ 59.55 per share. | 02 Aug 2024 | 1,169 | 113,724 (0%) | 0% | 59.6 | 69,614 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | Group Pres. Pharma & Consumer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 18,746 | 115,242 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Aristippos Gennadios | Group Pres. Pharma & Consumer | Sale of securities on an exchange or to another person at price $ 58.70 per share. | 26 Jul 2024 | 349 | 114,893 (0%) | 0% | 58.7 | 20,486 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | Group Pres. Pharma & Consumer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 1,505 | 96,863 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Aristippos Gennadios | Group Pres. Pharma & Consumer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.18 per share. | 08 Dec 2023 | 367 | 96,496 (0%) | 0% | 37.2 | 13,645 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | Group Pres. Pharma & Consumer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 1,590 | 96,948 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Gennadios Aristippos | Group Pres. Pharma & Consumer | Other type of transaction at price $ 0.00 per share. | 23 Aug 2023 | 1,590 | 94,962 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Aristippos Gennadios | Group Pres. Pharma & Consumer | Sale of securities on an exchange or to another person at price $ 44.49 per share. | 23 Aug 2023 | 396 | 96,552 (0%) | 0% | 44.5 | 17,618 | Common Stock |
| Catalent Inc. | Gennadios Aristippos | Group Pres. Pharma & Consumer | Other type of transaction at price $ 0.00 per share. | 23 Aug 2023 | 396 | 95,358 (0%) | 0% | - | Common Stock | |
| Catalent Inc. | Aristippos Gennadios | Group Pres. Pharma & Consumer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 19,756 | 19,756 | - | - | Options to purchase Common Stock | |
| Catalent Inc. | Aristippos Gennadios | Group Pres. Pharma & Consumer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 8,870 | 95,358 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Aristippos Gennadios | Group Pres. Pharma & Consumer | Sale of securities on an exchange or to another person at price $ 47.87 per share. | 01 Aug 2023 | 220 | 86,488 (0%) | 0% | 47.9 | 10,531 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | Group Pres. Pharma & Consumer | Sale of securities on an exchange or to another person at price $ 46.57 per share. | 01 Aug 2023 | 61 | 86,708 (0%) | 0% | 46.6 | 2,841 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | Group Pres. Pharma & Consumer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2022 | 6,771 | 88,414 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Aristippos Gennadios | Group Pres. Pharma & Consumer | Sale of securities on an exchange or to another person at price $ 103.04 per share. | 24 Aug 2022 | 1,645 | 86,769 (0%) | 0% | 103.0 | 169,501 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | Group Pres. Pharma & Consumer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2022 | 8,078 | 8,078 | - | - | Options to purchase Common Stock | |
| Catalent Inc. | Aristippos Gennadios | Group Pres. Pharma & Consumer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2022 | 1,859 | 81,643 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Aristippos Gennadios | Group Pres. Pharma & Consumer | Sale of securities on an exchange or to another person at price $ 106.90 per share. | 26 Jul 2022 | 403 | 79,784 (0%) | 0% | 106.9 | 43,081 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | Group Pres. Pharma & Consumer | Grant, award, or other acquisition of securities at price $ 107.02 per share. | 01 Jul 2022 | 18,689 | 80,187 (0%) | 0% | 107.0 | 2,000,097 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 4,017 | 61,498 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 8,008 | 59,743 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Sale of securities on an exchange or to another person at price $ 131.20 per share. | 26 Aug 2021 | 2,091 | 57,481 (0%) | 0% | 131.2 | 274,339 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Sale of securities on an exchange or to another person at price $ 130.29 per share. | 26 Aug 2021 | 171 | 59,572 (0%) | 0% | 130.3 | 22,280 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2021 | 4,579 | 4,579 | - | - | Options to purchase Common Stock | |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2021 | 885 | 51,735 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Sale of securities on an exchange or to another person at price $ 113.05 per share. | 26 Jul 2021 | 465 | 50,850 (0%) | 0% | 113.0 | 52,568 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Sale of securities on an exchange or to another person at price $ 104.42 per share. | 04 Jan 2021 | 110 | 51,315 (0%) | 0% | 104.4 | 11,486 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Sale of securities on an exchange or to another person at price $ 102.80 per share. | 21 Dec 2020 | 9,726 | 51,425 (0%) | 0% | 102.8 | 999,833 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2020 | 9,726 | 3,243 | - | - | Options to purchase Common Stock | |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.02 per share. | 21 Dec 2020 | 9,726 | 61,151 (0%) | 0% | 36.0 | 350,331 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2020 | 3,936 | 0 | - | - | Options to purchase Common Stock | |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.44 per share. | 21 Dec 2020 | 3,936 | 55,361 (0%) | 0% | 24.4 | 96,196 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Sale of securities on an exchange or to another person at price $ 102.95 per share. | 21 Dec 2020 | 3,936 | 51,425 (0%) | 0% | 102.9 | 405,211 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2020 | 10,737 | 55,409 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.71 per share. | 27 Aug 2020 | 4,226 | 51,183 (0%) | 0% | 87.7 | 370,662 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2020 | 400 | 51,583 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.71 per share. | 27 Aug 2020 | 158 | 51,425 (0%) | 0% | 87.7 | 13,858 | Common Stock |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2020 | 6,158 | 6,158 | - | - | Options to purchase Common Stock | |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2020 | 1,136 | 44,672 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Aristippos Gennadios | President Softgel & Oral Tech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.64 per share. | 24 Jul 2020 | 984 | 43,536 (0%) | 0% | 81.6 | 80,334 | Common Stock |